Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 14.80B | 13.70B |
| Research and development | 521M | 491M |
| Selling, general and administrative | 1.17B | 1.16B |
| Pre-tax income | 1.14B | 943M |
| Income tax | 214M | 118M |
| Net income | 921M | 824M |
| Earnings per share | 5.15 | 4.38 |
| Earnings per share, diluted | 5.11 | 4.33 |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.61B | 2.03B | 1.52B | 1.43B | 1.25B | 1.44B | 1.35B | 1.41B |
| Inventory | 4.56B | 4.28B | 4.46B |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | 1.31B | 1.01B |
| Depreciation and amortisation | 401M | 382M |
| Capital expenditure | 383M | 364M |
| Investing cash flow | −207M | −284M |
| Dividends paid | 18M | 12M |
| Share buybacks | 822M | 1.12B |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 4.34B |
| 4.27B |
| 4.07B |
| 4.41B |
| 4.38B |
| Total assets | 18.14B | 18.13B | 17.38B | 17.08B | 16.94B | 16.84B | 16.45B | 16.43B |
| Total liabilities | 10.14B | 10.25B | 9.89B | 9.64B | 9.67B | 9.63B | 9.50B | 9.58B |
| Equity | 8.00B | 7.88B | 7.49B | 7.43B | 7.28B | 7.20B | 6.95B | 6.85B |
| Shares outstanding | 174M | 174M | 176M | 178M | 181M | 183M | 186M | 187M |
| Shares issued | — | 175M | — | — | — | 184M | — | — |
| Financing cash flow | −543M | −1.45B |